Published in:

01-10-2006 | Clinical–Patient Studies

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status

Authors: Morris D. Groves, Vinay K. Puduvalli, Charles A. Conrad, Mark R. Gilbert, W. K. Alfred Yung, Kurt Jaeckle, Vivien Liu, Kenneth R. Hess, Kenneth D. Aldape, Victor A. Levin

Published in: Journal of Neuro-Oncology | Issue 1/2006